Premium
Molecular basis for Rh null syndrome: Identification of three new missense mutations in the Rh50 glycoprotein gene
Author(s) -
Huang ChengHan,
Cheng Guangjie,
Liu Zhi,
Chen Ying,
Reid Marion E.,
Halverson Gregory,
Okubo Yasuto
Publication year - 1999
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/(sici)1096-8652(199909)62:1<25::aid-ajh5>3.0.co;2-k
Subject(s) - missense mutation , exon , microbiology and biotechnology , transversion , biology , antigenicity , genetics , locus (genetics) , gene , antigen , mutation
Rh null is a rare autosomal recessive disorder characterized by an absence of Rh antigens and a varying degree of hemolytic anemia and spherostomatocytosis. We report studies of two Japanese Rh null cases and describe three new missense mutations of RHAG, the locus that encodes Rh50 glycoprotein and modulates Rh antigen expression. In Rh null (HT), RHAG harbored in exon 6 two G→A transitions, G TT→ A TT and G GA→ A GA, which cause Val 270 →Ile and Gly 280 →Arg substitutions, respectively. These missense mutations were cotransmitted from the propositus to the children and were predicted to reside in endoloop 5 and transmembrane (TM) segment 9, respectively. In Rh null (WO), RHAG contained in exon 9 a single G→T transversion, G G T→G T T, which caused a Gly 380 →Val missense change in TM12 segment. The G→T transversion, which is located at the +1 position of exon 9, had also affected pre‐mRNA splicing and caused partial exon skipping. Although both Rh null cases had a structurally normal RH antigen locus, hemagglutination and immunoblotting showed no expression of Rh antigens or proteins. These results correlate each mutation with a structural defect in the respective TM domain of Rh50 glycoprotein. Am. J. Hematol. 62:25–32, 1999. © 1999 Wiley‐Liss, Inc.